Skip to main content
Top
Published in: Medical Oncology 10/2014

01-10-2014 | Original Paper

Association between CCNE1 polymorphisms and the risk of breast cancer in a sample of southeast Iranian population

Authors: Shadi Amininia, Mohammad Hashemi, Mahboubeh Ebrahimi, Mohammad Ali Mashhadi, Seyed Mehdi Hashemi, Mohsen Taheri, Saeid Ghavami

Published in: Medical Oncology | Issue 10/2014

Login to get access

Abstract

Cyclin E1 (CCNE1) is a key proto-oncogene. The present study aimed to investigate the effects of single nucleotide polymorphisms in CCNE1 on the risk of breast cancer (BC) in an Iranian population in southeast of Iran. A total of 491 subjects including 266 BC patients and 225 healthy control women were participated in the study. Genotyping of CCNE1 rs3218073 and 72010703 polymorphisms was done using allele-specific polymerase chain reaction (AS-PCR) and rs1406 by PCR–RFLP method.Our findings showed that rs1406 C/A polymorphism increased the risk of BC in codominant (OR 1.60, 95 % CI 1.05–2.43, p = 0.032 CA vs CC; OR 2.35, 95 % CI 1.23–4.49, p = 0.011 AA vs CC) and dominant (OR 1.69, 95 % CI 1.22–2.56, p = 0.012 CA + AA vs CC) inheritance models. The rs1406 A allele increased the risk of BC (OR 1.37, 95 % CI 1.06–1.76, p = 0.019) in comparison with C allele. On the other hand, CCNE1 rs72010703 (4-bp I/D) and rs3218073 polymorphisms did not show any significant association with BC. This study indicates that CCNE1 rs1406 polymorphism may contribute to BC risk.
Literature
1.
go back to reference Wu JT, Kral JG. The NF-kappaB/IkappaB signaling system: a molecular target in breast cancer therapy. J Surg Res. 2005;123(1):158–69.PubMedCrossRef Wu JT, Kral JG. The NF-kappaB/IkappaB signaling system: a molecular target in breast cancer therapy. J Surg Res. 2005;123(1):158–69.PubMedCrossRef
2.
go back to reference Turashvili G, Bouchal J, Burkadze G, et al. Differentiation of tumours of ductal and lobular origin: II. Genomics of invasive ductal and lobular breast carcinomas. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2005;149(1):63–8.PubMedCrossRef Turashvili G, Bouchal J, Burkadze G, et al. Differentiation of tumours of ductal and lobular origin: II. Genomics of invasive ductal and lobular breast carcinomas. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2005;149(1):63–8.PubMedCrossRef
3.
go back to reference Youlden DR, Cramb SM, Dunn NA, et al. The descriptive epidemiology of female breast cancer: an international comparison of screening, incidence, survival and mortality. Cancer Epidemiol. 2012;36(3):237–48.PubMedCrossRef Youlden DR, Cramb SM, Dunn NA, et al. The descriptive epidemiology of female breast cancer: an international comparison of screening, incidence, survival and mortality. Cancer Epidemiol. 2012;36(3):237–48.PubMedCrossRef
4.
go back to reference Babu GR, Samari G, Cohen SP, et al. Breast cancer screening among females in Iran and recommendations for improved practice: a review. Asian Pac J Cancer Prev. 2011;12(7):1647–55.PubMed Babu GR, Samari G, Cohen SP, et al. Breast cancer screening among females in Iran and recommendations for improved practice: a review. Asian Pac J Cancer Prev. 2011;12(7):1647–55.PubMed
5.
go back to reference Kolahdoozan S, Sadjadi A, Radmard AR, et al. Five common cancers in Iran. Arch Iran Med. 2010;13(2):143–6.PubMed Kolahdoozan S, Sadjadi A, Radmard AR, et al. Five common cancers in Iran. Arch Iran Med. 2010;13(2):143–6.PubMed
6.
go back to reference Hashemi M, Fazaeli A, Ghavami S, et al. Functional polymorphisms of FAS and FASL gene and risk of breast cancer–pilot study of 134 cases. PLoS one. 2013;8(1):e53075.PubMedCrossRefPubMedCentral Hashemi M, Fazaeli A, Ghavami S, et al. Functional polymorphisms of FAS and FASL gene and risk of breast cancer–pilot study of 134 cases. PLoS one. 2013;8(1):e53075.PubMedCrossRefPubMedCentral
7.
go back to reference Hashemi M, Eskandari-Nasab E, Fazaeli A, et al. Association between polymorphisms of glutathione S-transferase genes (GSTM1, GSTP1 and GSTT1) and breast cancer risk in a sample Iranian population. Biomark Med. 2012;6(6):797–803.PubMedCrossRef Hashemi M, Eskandari-Nasab E, Fazaeli A, et al. Association between polymorphisms of glutathione S-transferase genes (GSTM1, GSTP1 and GSTT1) and breast cancer risk in a sample Iranian population. Biomark Med. 2012;6(6):797–803.PubMedCrossRef
8.
go back to reference Hashemi M, Eskandari-Nasab E, Fazaeli A, et al. Bi-directional PCR allele-specific amplification (bi-PASA) for detection of caspase-8–652 6 N ins/del promoter polymorphism (rs3834129) in breast cancer. Gene. 2012;505(1):176–9.PubMedCrossRef Hashemi M, Eskandari-Nasab E, Fazaeli A, et al. Bi-directional PCR allele-specific amplification (bi-PASA) for detection of caspase-8–652 6 N ins/del promoter polymorphism (rs3834129) in breast cancer. Gene. 2012;505(1):176–9.PubMedCrossRef
9.
go back to reference Eskandari-Nasab E, Hashemi M, Rezaei H, et al. Evaluation of UDP-glucuronosyltransferase 2B17 (UGT2B17) and dihydrofolate reductase (DHFR) genes deletion and the expression level of NGX6 mRNA in breast cancer. Mol Biol Rep. 2012;39(12):10531–9.PubMedCrossRef Eskandari-Nasab E, Hashemi M, Rezaei H, et al. Evaluation of UDP-glucuronosyltransferase 2B17 (UGT2B17) and dihydrofolate reductase (DHFR) genes deletion and the expression level of NGX6 mRNA in breast cancer. Mol Biol Rep. 2012;39(12):10531–9.PubMedCrossRef
10.
go back to reference Omrani M, Hashemi M, Eskanadri-Nasab E, et al. Hsa-mir-499 rs3746444 gene polymorphism is associated with susceptibility to breast cancer in an Iranian population. Biomark Med. 2014;8(2):257–65.CrossRef Omrani M, Hashemi M, Eskanadri-Nasab E, et al. Hsa-mir-499 rs3746444 gene polymorphism is associated with susceptibility to breast cancer in an Iranian population. Biomark Med. 2014;8(2):257–65.CrossRef
11.
go back to reference Hashemi M, Amininia S, Ebrahimi M, et al. Association between LAPTM4B gene polymorphism and breast cancer susceptibility in an Iranian population. Med Oncol. 2014;31(8):111.PubMedCrossRef Hashemi M, Amininia S, Ebrahimi M, et al. Association between LAPTM4B gene polymorphism and breast cancer susceptibility in an Iranian population. Med Oncol. 2014;31(8):111.PubMedCrossRef
12.
go back to reference Malumbres M, Barbacid M. To cycle or not to cycle: a critical decision in cancer. Nat Rev Cancer. 2001;1(3):222–31.PubMedCrossRef Malumbres M, Barbacid M. To cycle or not to cycle: a critical decision in cancer. Nat Rev Cancer. 2001;1(3):222–31.PubMedCrossRef
13.
go back to reference Ezhevsky SA, Ho A, Becker-Hapak M, et al. Differential regulation of retinoblastoma tumor suppressor protein by G(1) cyclin-dependent kinase complexes in vivo. Mol Cell Biol. 2001;21(14):4773–84.PubMedCrossRefPubMedCentral Ezhevsky SA, Ho A, Becker-Hapak M, et al. Differential regulation of retinoblastoma tumor suppressor protein by G(1) cyclin-dependent kinase complexes in vivo. Mol Cell Biol. 2001;21(14):4773–84.PubMedCrossRefPubMedCentral
14.
go back to reference Hartwell LH, Weinert TA. Checkpoints: controls that ensure the order of cell cycle events. Science. 1989;246(4930):629–34.PubMedCrossRef Hartwell LH, Weinert TA. Checkpoints: controls that ensure the order of cell cycle events. Science. 1989;246(4930):629–34.PubMedCrossRef
15.
go back to reference Leung SY, Ho C, Tu IP, et al. Comprehensive analysis of 19q12 amplicon in human gastric cancers. Mod Pathol. 2006;19(6):854–63.PubMed Leung SY, Ho C, Tu IP, et al. Comprehensive analysis of 19q12 amplicon in human gastric cancers. Mod Pathol. 2006;19(6):854–63.PubMed
17.
go back to reference Spruck CH, Won KA, Reed SI. Deregulated cyclin E induces chromosome instability. Nature. 1999;401(6750):297–300.PubMedCrossRef Spruck CH, Won KA, Reed SI. Deregulated cyclin E induces chromosome instability. Nature. 1999;401(6750):297–300.PubMedCrossRef
18.
go back to reference Song H, Hogdall E, Ramus SJ, et al. Effects of common germ-line genetic variation in cell cycle genes on ovarian cancer survival. Clin Cancer Res. 2008;14(4):1090–5.PubMedCrossRefPubMedCentral Song H, Hogdall E, Ramus SJ, et al. Effects of common germ-line genetic variation in cell cycle genes on ovarian cancer survival. Clin Cancer Res. 2008;14(4):1090–5.PubMedCrossRefPubMedCentral
19.
go back to reference Han JY, Wang H, Xie YT, et al. Association of germline variation in CCNE1 and CDK2 with breast cancer risk, progression and survival among Chinese Han women. PLoS one. 2012;7(11):e49296.PubMedCrossRefPubMedCentral Han JY, Wang H, Xie YT, et al. Association of germline variation in CCNE1 and CDK2 with breast cancer risk, progression and survival among Chinese Han women. PLoS one. 2012;7(11):e49296.PubMedCrossRefPubMedCentral
20.
go back to reference Liu Y, Cai H, Liu J, et al. A miR-151 binding site polymorphism in the 3′-untranslated region of the cyclin E1 gene associated with nasopharyngeal carcinoma. Biochem Biophys Res Commun. 2013;432(4):660–5.PubMedCrossRef Liu Y, Cai H, Liu J, et al. A miR-151 binding site polymorphism in the 3′-untranslated region of the cyclin E1 gene associated with nasopharyngeal carcinoma. Biochem Biophys Res Commun. 2013;432(4):660–5.PubMedCrossRef
21.
go back to reference Driver KE, Song H, Lesueur F, et al. Association of single-nucleotide polymorphisms in the cell cycle genes with breast cancer in the British population. Carcinogenesis. 2008;29(2):333–41.PubMedCrossRefPubMedCentral Driver KE, Song H, Lesueur F, et al. Association of single-nucleotide polymorphisms in the cell cycle genes with breast cancer in the British population. Carcinogenesis. 2008;29(2):333–41.PubMedCrossRefPubMedCentral
22.
go back to reference Olson JE, Wang X, Pankratz VS, et al. Centrosome-related genes, genetic variation, and risk of breast cancer. Breast Cancer Res Treat. 2011;125(1):221–8.PubMedCrossRefPubMedCentral Olson JE, Wang X, Pankratz VS, et al. Centrosome-related genes, genetic variation, and risk of breast cancer. Breast Cancer Res Treat. 2011;125(1):221–8.PubMedCrossRefPubMedCentral
23.
go back to reference Rothman N, Garcia-Closas M, Chatterjee N, et al. A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci. Nat Genet. 2010;42(11):978–84.PubMedCrossRefPubMedCentral Rothman N, Garcia-Closas M, Chatterjee N, et al. A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci. Nat Genet. 2010;42(11):978–84.PubMedCrossRefPubMedCentral
24.
go back to reference Hashemi M, Eskandari-Nasab E, Fazaeli A, et al. Association of genetic polymorphisms of glutathione-S-transferase genes (GSTT1, GSTM1, and GSTP1) and susceptibility to nonalcoholic fatty liver disease in Zahedan. Southeast Iran. DNA Cell Biol. 2012;31(5):672–7.CrossRef Hashemi M, Eskandari-Nasab E, Fazaeli A, et al. Association of genetic polymorphisms of glutathione-S-transferase genes (GSTT1, GSTM1, and GSTP1) and susceptibility to nonalcoholic fatty liver disease in Zahedan. Southeast Iran. DNA Cell Biol. 2012;31(5):672–7.CrossRef
25.
go back to reference Murali A, Nalinakumari KR, Thomas S, et al. Association of single nucleotide polymorphisms in cell cycle regulatory genes with oral cancer susceptibility. Br J Oral Maxillofac Surg. 2014;52(7):652–8.PubMedCrossRef Murali A, Nalinakumari KR, Thomas S, et al. Association of single nucleotide polymorphisms in cell cycle regulatory genes with oral cancer susceptibility. Br J Oral Maxillofac Surg. 2014;52(7):652–8.PubMedCrossRef
26.
go back to reference Azzato EM, Driver KE, Lesueur F, et al. Effects of common germline genetic variation in cell cycle control genes on breast cancer survival: results from a population-based cohort. Breast Cancer Res. 2008;10(3):R47.PubMedCrossRefPubMedCentral Azzato EM, Driver KE, Lesueur F, et al. Effects of common germline genetic variation in cell cycle control genes on breast cancer survival: results from a population-based cohort. Breast Cancer Res. 2008;10(3):R47.PubMedCrossRefPubMedCentral
Metadata
Title
Association between CCNE1 polymorphisms and the risk of breast cancer in a sample of southeast Iranian population
Authors
Shadi Amininia
Mohammad Hashemi
Mahboubeh Ebrahimi
Mohammad Ali Mashhadi
Seyed Mehdi Hashemi
Mohsen Taheri
Saeid Ghavami
Publication date
01-10-2014
Publisher
Springer US
Published in
Medical Oncology / Issue 10/2014
Print ISSN: 1357-0560
Electronic ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-014-0189-z

Other articles of this Issue 10/2014

Medical Oncology 10/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.